<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03537430</url>
  </required_header>
  <id_info>
    <org_study_id>EC-2018-HS-001</org_study_id>
    <nct_id>NCT03537430</nct_id>
  </id_info>
  <brief_title>Totally no Tube (TNT) Uniportal Video-assisted Thoracoscopic Surgery (VATS) VS Traditional Uniportal VATS for Mediastinal Tumor</brief_title>
  <official_title>Totally no Tube (TNT) Uniportal Video-assisted Thoracoscopic Surgery (VATS) VS Traditional Uniportal VATS for Mediastinal Tumor: A Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xueying Yang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shengjing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      TNT surgery is a new area of exploration and evolution in thoracic minimal invasive surgery.
      TNT Uniportal Video-assisted Thoracoscopic Surgery (VATS) has become popular during
      mediastinal tumors resection. However, there has been little randomized controlled trials
      into the associated feasibility and advantage. The aim of our RCT was to evaluate the
      feasibility and advantage of TNT Uniportal VATS for mediastinal tumors resection and its
      significance in Fast Track Surgery (FTS). This is a single-center prospective randomized
      controlled trial. 98 patients aged between 18 and 75 years with clinically mediastinal tumors
      were randomly assigned to two groups, 50 patients received TNT uniportal VATS mediastinal
      tumor resection (TNT group) and 48 patients underwent traditional uniportal VATS mediastinal
      tumor resection (control group), the short-term perioperative outcomes would be reported
      here.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was designed as a single-center prospective randomized controlled trial. The trial
      recruited patients aged from 18 to 75 years with a diagnosis of mediastinal tumor.
      Preoperative chest CT examination showed that shape of the mediastinal tumor was regular,
      boundary was clear, and maximum diameter of the mass was less than 4 cm. Other inclusion
      criteria included capability of giving consent and adequate organ function to tolerate
      uniportal thoracoscopy mediastinal tumor resection. The exclusion criteria are described as
      follows: preoperative examination showed that the tumor invaded the surrounding blood
      vessels, pericardium, lung and other tissues or had distant metastasis; preoperative
      complications include severe coronary heart disease, arrhythmia and other serious
      cardiopulmonary diseases; large masses, difficult surgical procedures; manifestations of
      myasthenia gravis; hypovolemia, blood disorders, or abnormal clotting mechanism; pulmonary
      function and arterial blood gas analysis showed that patients could not tolerate surgery;
      previous thoracotomy; inability to obtain consent. Furthermore, the exclusion criteria were
      defifined as follows: intraoperative pleural adhesion or technical challenge to achieve
      hemostasis that make conversion from VATS to thoracotomy; clinician decides the patient
      should not continue the trial according to individual condition; patient withdraws from the
      trial. According to International Conference on Harmonisation, all participants gave written
      informed consent. Our RCT was launched in April 2018, which conducted in accordance with the
      Declaration of Helsinki and good clinical practice according to the International Conference
      on Harmonization guidelines. The ethics committee of The Fourth Affiliated Hospital of
      Medical Sciences, Liaoning, China, approved this study (approval number: EC-2018-HS-01).

      After eligibility had been confirmed and inform consents obtained, the investigator
      registered patients to ensure allocation concealment. Next we randomly enrolled patients to
      TNT group and control group in accordance with a list of randomization numbers. This list was
      generated in the trial statistician's computer. Allocation was communicated by telephone by
      the trial coordinator. Neither patients nor any investigators were masked to treatment
      allocation.

      The patients underwent routine physical examination, hematologic and biochemical tests,
      arterial blood gas analysis, pulmonary function test and computed tomography. Uniportal VATS
      mediastinal tumor resection was the standard surgical intervention according to the protocol.
      Patients in TNT group underwent TNT uniportal VATS mediastinal tumor resection, patients in
      control group underwent traditional uniportal VATS. Pre-, peri-, and postoperative details
      and outcome variables of patients were collected.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Actual">August 20, 2019</completion_date>
  <primary_completion_date type="Actual">August 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This is a single-center prospective randomized controlled trial. 98 patients aged between 18 and 75 years with clinically mediastinal tumors were randomly assigned to two groups, 50 patients received TNT uniportal VATS mediastinal tumor resection (TNT group) and 48 patients underwent traditional uniportal VATS mediastinal tumor resection (control group), the short-term perioperative outcomes would be reported here.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
    <masking_description>This study is a prospective randomized controlled clinical trial. Participants, care provider, and investigator all know the grouping situation. The Investigator collect the information and observation indicators of the two groups of participants and send to the Outcomes Assessor . The Outcomes Assessor does not know the grouping situation of each participant.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>operative time</measure>
    <time_frame>1 day</time_frame>
    <description>Anesthesia completed to the end of the operation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intubation/laryngeal mask completion time</measure>
    <time_frame>1 day</time_frame>
    <description>Intubation/laryngeal mask completion time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>duration of postoperative pain</measure>
    <time_frame>10 days</time_frame>
    <description>Postoperative pain duration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>VAS pain scores</measure>
    <time_frame>5 days</time_frame>
    <description>The VAS pain score was given to patients and the pain scores were recorded at 6h, 12h, 24h, 48h, and 72h postoperatively.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraoperative blood loss</measure>
    <time_frame>1 day</time_frame>
    <description>Intraoperative blood loss</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The time of early ambulation after operation</measure>
    <time_frame>1 day</time_frame>
    <description>The time from the patient's postoperative pushback to the first bedtime</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative hospital stay</measure>
    <time_frame>15 days</time_frame>
    <description>Postoperative hospital stay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>hospitalization expenses</measure>
    <time_frame>15 days</time_frame>
    <description>The total cost of hospitalization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraoperative oxygen saturation, SpO2</measure>
    <time_frame>1 day</time_frame>
    <description>Intraoperative oxygen saturation, SpO2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraoperative mean arterial pressure, MAP</measure>
    <time_frame>1 day</time_frame>
    <description>Intraoperative mean arterial pressure, MAP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative complication rate</measure>
    <time_frame>15 days</time_frame>
    <description>Incidence of postoperative complications such as respiratory, cardiovascular and intubation-related complications</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraoperative heart rate, HR</measure>
    <time_frame>1 day</time_frame>
    <description>Intraoperative heart rate, HR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative extubation time</measure>
    <time_frame>1 day</time_frame>
    <description>Postoperative extubation time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative feeding time</measure>
    <time_frame>1 day</time_frame>
    <description>Postoperative feeding time</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Mediastinal Tumor</condition>
  <arm_group>
    <arm_group_label>TNT Uniportal Video-assisted Thoracoscopic Surgery</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This group of patients underwent TNT uniportal VATS mediastinal tumor resection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Uniportal Video-assisted Thoracoscopic Surgery</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This group of patients underwent traditional uniportal VATS mediastinal tumor resection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TNT uniportal VATS mediastinal tumor resection</intervention_name>
    <description>TNT uniportal video-assisted thoracoscopic surgery refers to the use of conventional uniportal video-assisted thoracoscopic surgery, the use of laryngeal mask anesthesia instead of tracheal intubation anesthesia, intraoperative catheter was not retained, postoperative chest catheter placement.</description>
    <arm_group_label>TNT Uniportal Video-assisted Thoracoscopic Surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Traditional uniportal VATS mediastinal tumor resection</intervention_name>
    <description>The surgical procedures followed principles of mediastinal tumor resectionï¼Œuniportal video-assisted thoracoscopic surgery in mediastinal tumor resection.</description>
    <arm_group_label>Uniportal Video-assisted Thoracoscopic Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        The trial recruited patients aged from 18 to 75 years with a diagnosis of mediastinal
        tumor. Preoperative chest CT examination showed that shape of the mediastinal tumor was
        regular, boundary was clear, and maximum diameter of the mass was less than 4 cm. Other
        inclusion criteria included capability of giving consent and adequate organ function to
        tolerate uniportal thoracoscopy mediastinal tumor resection.

        Exclusion Criteria:

        Preoperative examination showed that the tumor invaded the surrounding blood vessels,
        pericardium, lung and other tissues or had distant metastasis; preoperative complications
        include severe coronary heart disease, arrhythmia and other serious cardiopulmonary
        diseases; large masses, difficult surgical procedures; manifestations of myasthenia gravis;
        hypovolemia, blood disorders, or abnormal clotting mechanism; pulmonary function and
        arterial blood gas analysis showed that patients could not tolerate surgery; previous
        thoracotomy; inability to obtain consent. Furthermore, the exclusion criteria were
        defifined as follows: intraoperative pleural adhesion or technical challenge to achieve
        hemostasis that make conversion from VATS to thoracotomy; clinician decides the patient
        should not continue the trial according to individual condition; patient withdraws from the
        trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Fourth Affiliated Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Zhao ZR, Lau RWH, Ng CSH. Anaesthesiology for uniportal VATS: double lumen, single lumen and tubeless. J Vis Surg. 2017 Aug 21;3:108. doi: 10.21037/jovs.2017.07.05. eCollection 2017. Review.</citation>
    <PMID>29078668</PMID>
  </results_reference>
  <results_reference>
    <citation>Petersen RH, Holbek BL, Hansen HJ, Kehlet H. Video-assisted thoracoscopic surgery-taking a step into the future. Eur J Cardiothorac Surg. 2017 Apr 1;51(4):694-695. doi: 10.1093/ejcts/ezw381.</citation>
    <PMID>28007878</PMID>
  </results_reference>
  <results_reference>
    <citation>Mineo TC, Tamburrini A, Perroni G, Ambrogi V. 1000 cases of tubeless video-assisted thoracic surgery at the Rome Tor Vergata University. Future Oncol. 2016 Dec;12(23s):13-18. Epub 2016 Sep 30. Review.</citation>
    <PMID>27686131</PMID>
  </results_reference>
  <results_reference>
    <citation>Cui F, Liu J, Li S, Yin W, Xin X, Shao W, He J. Tubeless video-assisted thoracoscopic surgery (VATS) under non-intubated, intravenous anesthesia with spontaneous ventilation and no placement of chest tube postoperatively. J Thorac Dis. 2016 Aug;8(8):2226-32. doi: 10.21037/jtd.2016.08.02.</citation>
    <PMID>27621880</PMID>
  </results_reference>
  <results_reference>
    <citation>Gonzalez-Rivas D, Yang Y, Guido W, Jiang G. Non-intubated (tubeless) uniportal video-assisted thoracoscopic lobectomy. Ann Cardiothorac Surg. 2016 Mar;5(2):151-3. doi: 10.21037/acs.2016.03.02. Review.</citation>
    <PMID>27134844</PMID>
  </results_reference>
  <results_reference>
    <citation>Fernandes P, Lareiro S, Vouga L, Guerra M, Miranda J. Uniportal Video-Assisted Thorascoscopic Surgery - The New Paradigm in the Surgical Treatment of Lung Cancer. Rev Port Cir Cardiotorac Vasc. 2017 Jul-Dec;24(3-4):127.</citation>
    <PMID>29701369</PMID>
  </results_reference>
  <results_reference>
    <citation>Migliore M. Uniportal video-assisted thoracic surgery, and the uni-surgeon: new words for the contemporary world. J Vis Surg. 2018 Mar 7;4:45. doi: 10.21037/jovs.2018.02.11. eCollection 2018. Erratum in: J Vis Surg. 2018 Jun 30;4:127.</citation>
    <PMID>29682455</PMID>
  </results_reference>
  <results_reference>
    <citation>Bedetti B, Solli P, Lawrence D, Panagiotopoulos N, Hayward M, Scarci M. Single port video-assisted thoracoscopic thymectomy. J Vis Surg. 2016 Sep 1;2:149. doi: 10.21037/jovs.2016.08.07. eCollection 2016. Review.</citation>
    <PMID>29078536</PMID>
  </results_reference>
  <results_reference>
    <citation>Ooi A, Sibayan M. Uniportal video assisted thoracoscopic surgery thymectomy (right approach). J Vis Surg. 2016 Jan 17;2:13. doi: 10.3978/j.issn.2221-2965.2015.12.14. eCollection 2016.</citation>
    <PMID>29078441</PMID>
  </results_reference>
  <results_reference>
    <citation>Ooi A, Qiang F. Uniportal video assisted thoracoscopic surgery thymectomy (left approach). J Vis Surg. 2016 Jan 16;2:12. doi: 10.3978/j.issn.2221-2965.2015.12.18. eCollection 2016.</citation>
    <PMID>29078440</PMID>
  </results_reference>
  <results_reference>
    <citation>Dunning J. Video-assisted thoracoscopic microthymectomy. Ann Cardiothorac Surg. 2015 Nov;4(6):550-5. doi: 10.3978/j.issn.2225-319X.2015.11.04. Review.</citation>
    <PMID>26693152</PMID>
  </results_reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 15, 2018</study_first_submitted>
  <study_first_submitted_qc>May 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2018</study_first_posted>
  <last_update_submitted>August 21, 2019</last_update_submitted>
  <last_update_submitted_qc>August 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shengjing Hospital</investigator_affiliation>
    <investigator_full_name>Xueying Yang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>TNT (Totally no tube)</keyword>
  <keyword>uniportal VATS</keyword>
  <keyword>mediastinal tumor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mediastinal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

